Physician profile
Jon M Johnson
NPI 1285992107
$636.59
in general payments reported to CMS, 2019-2025
14 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $129 · 2021: $75.65 · 2022: $122 · 2023: $30.11 · 2024: $47.63 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $220.55 | 2019-2023 | Mounjaro, Trulicity |
| Optinose US, INC. | $89.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $76.22 | 2019-2022 | |
| Abbvie INC. | $41.49 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $38.33 | 2020-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.40 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $22.18 | 2019 | |
| Lundbeck LLC | $20.40 | 2024 | Rexulti |
| Sanofi Pasteur INC. | $18.75 | 2020 | |
| Boston Scientific Corporation | $18.33 | 2025 | Watchman Access System |
| Bioventus LLC | $15.16 | 2022 | |
| Novo Nordisk INC | $14.94 | 2020 | |
| Abbott Laboratories | $13.53 | 2024 | Freestyle Libre 3 |
| Amgen INC. | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.